Medical practice; ensure that stem cell therapies are used to advance medical treatments and improve patient outcomes in an ethical manner that does not involve stem cells derived from aborted fetuses

Georgia file HB1275, before the Georgia Legislature. Passed as of 2026-05-11.

Latest action: House Date Signed by Governor

What it does

Patients seeking stem cell therapy face source restrictions Georgia patients cannot receive stem cell treatments derived from aborted fetal tissue; doctors must disclose the source of any stem cells used and obtain written patient consent before treatment begins.

The bigger picture

Research and treatment options may narrow in state Georgia medical facilities and researchers lose access to fetal-derived stem cell lines that are used in some regenerative medicine research, potentially limiting availability of certain experimental treatments and slowing adoption of therapies developed elsewhere using those sources.

Official summary

A BILL to be entitled an Act to amend Article 2 of Chapter 34 of Title 43 of the Official Code of Georgia Annotated, relating to medical practice, so as to ensure that stem cell therapies are used to advance medical treatments and improve patient outcomes in an ethical manner that does not involve stem cells derived from aborted fetuses; to provide for definitions; to provide for the designation of a physician assistant or nurse practitioner; to provide for certain requirements and patient protections; to provide for notice; to provide for consent; to provide for certain exceptions; to provide for the use of Georgia facilities; to provide for related matters; to provide for legislative findings; to repeal conflicting laws; and for other purposes.

See everything up for a vote · This week in Georgia · See what we have filed with the clerk